NCT07287150 2026-03-05
InavoPC
Hoffmann-La Roche
Phase 2 Recruiting
Clinical Trials
16 trialsNCT05217940 2025-08-22
SWAN
Icahn School of Medicine at Mount Sinai
Phase NA Recruiting
NCT06990633 2025-05-25
LYNX
Izmir Ataturk Training and Research Hospital
Not yet recruiting
NCT05443412 2025-05-20
Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection
Chinese University of Hong Kong
Recruiting
NCT06299202 2024-09-27
CERePred
Hospices Civils de Lyon
Phase NA Recruiting
NCT06278610 2024-05-21
Pre-PEX
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT05081141 2024-05-07
HHV8 and Solid Organ Transplantation
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Recruiting
NCT06394050 2024-05-01
Label-free Raman Spectroscopy for Discrimination Between Breast Cancer Tumor and Adjacent Tissues After Neoadjuvant Treatment
RenJi Hospital
Not yet recruiting
NCT03981809 2023-08-22
PainsCan
Universitaire Ziekenhuizen KU Leuven
Completed
NCT05645133 2023-06-15
QPlus Pediatric Reference Interval
HemoSonics LLC
Terminated
NCT04313140 2023-02-09
Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging
Poitiers University Hospital
Phase NA Recruiting
NCT04523389 2020-08-21
ExoColon
Centre Hospitalier Universitaire Dijon
Unknown
NCT03067389 2019-01-15
Combined Breast Cancer Risk Study
Myriad Genetic Laboratories, Inc.
Completed
NCT03641105 2018-08-21
Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma
Shanghai Zhongshan Hospital
Unknown
NCT03081455 2017-08-08
Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes
Myriad Genetic Laboratories, Inc.
Completed
NCT00633620 2008-03-12
BECOP-2
Charite University, Berlin, Germany
Phase NA Completed